Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Sulagna Dutta, orcid.org/0000-0002-7893-5282
As AD prevalence rapidly escalates projected to affect over 50 million individuals worldwide by 2050 and with traditional drug development yielding limited therapeutic breakthroughs, repurposing offers a pragmatic alternative to conventional de novo drug discovery (Fatima et al., 2024)
Once fully dissolved, the solution should be clear and free of particles
Effects of common anticoagulants (heparin, citrate and EDTA) on routine plasma biochemistry of cattle
US$ 24.86
US$ 20.20
:max_bytes(150000):strip_icc()/VWH-GettyImages-2178836417-ee318a41780b44e9af3ff47de83fafd7.jpg)
US$ 24.92
